Month: February 2022

Financial Planning for 2021 Planning for the future can be a difficult and stressful process. There are so many events and deadlines to keep track of and, when it comes to personal finances, missing an important date could be both figuratively and literally costly. To add a little sanity to your life, we created a
0 Comments
E-commerce firm ContextLogic (NASDAQ:WISH) stock rose a strong 16% in intraday trading on Monday without any apparent stock-related news to suggest a change in the troubled company’s fortunes. Source: sdx15 / Shutterstock.com WISH stock is still down 91% over the past year. Could Monday’s strong rally point to a sustained rebound in February? An Imminent
0 Comments
Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months, and the first shots could come by the end of February, according to news reports Monday night. The New York Times and Washington Post both reported Pfizer Inc.  PFE, -0.50% and its vaccine partner, BioNTech
0 Comments
Intel (NASDAQ:INTC) CEO Pat Gelsinger is using “tech sovereignty” to fuel the stock’s comeback, with hefty government aid. INTC stock has some big changes on the horizon. Source: Sundry Photography / Shutterstock.com Intel’s decision to put its new $20 billion chip plant outside Columbus, Ohio was fueled by over $2 billion in state government “incentives.”
0 Comments
Key Takeaways Revenue for AMD’s Enterprise, Embedded and Semi-Custom segment came in above expectations. The Enterprise, Embedded and Semi-Custom segment has been growing much faster than the company’s other main segment as processing chips are being embedded in more and more products. AMD expects revenue to grow approximately 45% year over year in Q1 FY
0 Comments
The earnings season has picked up momentum, with many stocks reporting over the next few weeks. Analysts predict to see robust earnings growth in old economy stocks that include cyclical sectors, energy, materials, industrials, and consumer discretionary names. Meanwhile, following recent price declines, many tech shares are also offering better value. Therefore, today’s article introduces
0 Comments
Biotech is big business. And getting bigger. That’s good news if you’re investing in biotech stocks. According to market research firm Grand View Research, the global biotechnology industry is expected to reach $2.44 trillion by 2028, giving it a compound annual growth rate (CAGR) of 16% over the next seven years. Driving that huge growth
0 Comments
JohnnyGreig | E+ | Getty Images Embracing diversity is good for business. More diverse companies, both at board level and throughout the workforce, can outperform on financial metrics such as return on equity and higher earnings per share. They can also generate higher returns compared to their indices, according to GS Sustain 2020. Moreover, embracing
0 Comments